The Fund seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index, which includes common stocks of companies in the pharmaceutical industry. The Fund normally invests at least 80% of its assets in securities of the Index.
|Non Classified Equity||2.56%|
|Symbol||Company Name||% Of Assets|
|NVO||Novo Nordisk A/S DR||5.71%|
|AZNN||AstraZeneca PLC DR||5.69%|
|PFE||Pfizer Inc ORD||5.52%|
|LLY||Eli Lilly and Co ORD||5.45%|
|ABBV||Abbvie Inc ORD||5.06%|
|JNJ||Johnson & Johnson ORD||4.99%|
|ZTS||Zoetis Inc ORD||4.97%|
|CTLT||Catalent Inc ORD||4.96%|
|MRK||Merck & Co Inc ORD||4.92%|
|BMY||Bristol-Myers Squibb Co ORD||4.88%|
|Market Capitalization||133.11 B|
|Total Net Assets||341.20|
|Sub Asset Class||Global Health/Biotechnology Fds|
|Number Of Holdings||25|
Join the Action Alerts PLUS Community today!
James “Rev Shark” Deporre counsels patience when faced with a setup that goes awry
Disney's CEO warns that COVID-19 related headwinds will have an impact of subscription growth.
Facebook's 10-inch Portal Go, costs $199, and the Portal+, with a 14-inch HD tilting screen, costs $349. Both will begin shipping Oct. 19.
Zoom Video has run into trouble with U.S. regulators before over its ties to China.
Jim Cramer discusses why it's time to sell some crypto investments and Tuesday's market.
Real Money’s Jonathan Heller looks at the strategy for buying stocks poised to rebound after the first of the year.
'Metrics we use to track intra-quarter pass sales appear robust,' writes KeyBanc analyst Brett Andress. He has a $355 price target.
Failed bounces are a part of any corrective action in the market, James "Rev Shark" Deporre says.